| Sublingual versus oral misoprostol for uterine evacuation following early pregnancy failure. | |
| | |
MedLine Citation:
|
PMID: 19426973 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To compare the efficacy of misoprostol administered sublingually or orally for uterine evacuation after early pregnancy failure. METHOD: Forty-eight hours after receiving 200 mg of mifepristone orally, 100 women were randomized to receive misoprostol sublingually or orally. RESULTS: The evacuation rates were 92% in the sublingual and 84% in the oral administration group; the mean+/-SD induction-to-evacuation intervals were 5.6+/-4.54 hours and 9.44+/-5.61 hours, this difference being significant; and the adverse effects were similar in the 2 groups. CONCLUSION: The sublingual route was found to be as effective but faster than the oral route for uterine evacuation after early pregnancy failure. |
| | |
Authors:
|
Beenu Kushwah; Abha Singh |
Related Documents
:
|
3464043 - Effect upon the human myometrium during early pregnancy of prostaglandin e2 and its ana... 15970853 - Comparison of perinatal grief after dilation and evacuation or labor induction in secon... 17130433 - Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Randomized Controlled Trial Date: 2009-05-07 |
Journal Detail:
|
Title: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Volume: 106 ISSN: 1879-3479 ISO Abbreviation: Int J Gynaecol Obstet Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2009-06-08 Completed Date: 2009-08-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0210174 Medline TA: Int J Gynaecol Obstet Country: Ireland |
Other Details:
|
Languages: eng Pagination: 43-5 Citation Subset: IM |
Affiliation:
|
Lady Harding Medical College, Delhi, India. baps_aps@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortifacient Agents, Nonsteroidal
/
administration & dosage,
adverse effects,
therapeutic use* Abortion, Incomplete / drug therapy* Administration, Oral Administration, Sublingual Adult Female Humans Misoprostol / administration & dosage, adverse effects, therapeutic use* Pregnancy Time Factors Treatment Outcome Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Changes in population demographics and the future incidence of hip fracture.
Next Document: From reproductive choice to reproductive justice.